Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5280b5c2e4d4bb68735cc9a085214c0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcad3e245da588d0346a1176b59986e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb880bf0b32905833d71c570286c8ded http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19804bb15f463e7b9a25b0c129604408 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
filingDate |
2005-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1bb40ebc1ea837a6957595e6c1dccf9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60095182235bf88ea54ec0ffa1bf4ca3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58796cecd436dc55770943fb6fc35c03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_478171ccaf3fad3efe4e0089ee01eab4 |
publicationDate |
2011-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2011009326-A1 |
titleOfInvention |
Methods or use of lamin b1 nuclear antigen, fragments and compositions thereof, for inhibiting or reducing a thrombotic event |
abstract |
A method for preventing a thrombotic event in a patient susceptible to such an event, which comprises the step of administering an effective amount of a lamin 131 nuclear (LB1) antigen to said patient is provided along with an anti-thrombotic composition which comprises an effective amount of a lamin 131 nuclear (LB1) antigen and a pharmaceutically acceptable carrier. |
priorityDate |
2004-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |